Table 1.
Baseline patient demographic and clinical characteristics.
| Characteristic | Video Visit Cohort (n=134) | In-Person Cohort (n=140) | P-Value |
|---|---|---|---|
| Age, years | 42.8 ± 8.9 | 45.0 ± 12.1 | .10 |
| Male (%) | 97 (74) | 111 (79) | .26 |
| Systolic BP, mmHg | 123 ± 13 | 128 ± 21 | .014 |
| Diastolic BP, mmHg | 78 ± 11 | 81 ± 9 | .016 |
| Lipid panel | |||
| Total cholesterol, mg/dL | 196 ± 43 | 184 ± 49 | .053 |
| LDL-C, mg/dL | 130 ± 39 | 114 ± 43 | .003 |
| HDL-C, mg/dL | 50 ± 14 | 50 ± 19 | .88 |
| Triglycerides, mg/dL | 125 ± 68 | 129 ± 80 | .65 |
| Statin use (%) | 30 (22) | 54 (39) | .004 |
| HbA1c, % | 5.9 ± 1.1 | 5.7 ± 0.7 | .27 |
| Body mass index, kg/m2 | 26.3 ± 4.6 | 26.8 ± 3.8 | .36 |
| Smoking status (%) | |||
| Non-smoker | 101 (75) | 114 (81) | .99 |
| Former smoker | 19 (14) | 20 (14) | .86 |
| Current smoker | 3 (2.2) | 6 (4.3) | .50 |
Mean ± standard deviation is reported for continuous variables. Data were available for >90% of patients except for lipid panel and HbA1c. BP denotes blood pressure, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, HbA1c hemoglobin A1c.